http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ac3774232601892621c05af507546bc
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Zaitsev |
| name | Sergei Zaitsev |
| given-name | Sergei |
| organization-name | Program in Targeted Therapeutics, Institute for Translational Medicine and Therapeutics and Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia; Department of Molecular Medicine, Rolf Luft Center for Diabetes Research, Department of Medical Biochemistry and Biophysics and Microbiology and Tumor Biology Center, Karolinska Institutet, SE-171 76 Stockholm, Sweden; and Department of Medical Biosciences and Physiological Chemistry, Umeå University, SE-901 87 Umeå, Sweden IFEM, University of Pennsylvania School of Medicine, One John Morgan Building, 3620 Hamilton Walk, Philadelphia, PA 19104-6068, USA. Department of Pathology and Laboratory Medicine and Department of Pharmacology, University of Pennsylvania, Philadelphia; and Department of Fundamental Medicine, School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia. Institute for Environmental Medicine,; Department of Pharmacology, and The Rolf Center for Diabetes Research, Department of Molecular Medicine, Endocrine and Diabetes Unit, Karolinska Hospital and Institute (C.-G.O., S.Z., P.-O.B., S.E.), S-171 76 Stockholm Program in Targeted Therapeutics, Institute for Translational Medicine and Therapeutics, and Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, PA; Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Pharmacology, The Institute for Environmental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA Institute for Translational Medicine & Therapeutics and Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-5158, United States From the Institute for Environmental Medicine, the Department of Pathology and Laboratory Medicine, and the Department of Pharmacology and Targeted Therapeutics Program of the Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia; the Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville; Elusys Therapeutics, Pine Brook, NC; and Centro Nacional De Investigationes Cardiovasculares (CNIC), Madrid, Spain. Department of PharmacologyUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA; Center for Targeted Therapeutics and Translational NanomedicineInstitute for Translational Medicine and TherapeuticsUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA; Department of Pathology and Laboratory MedicineThe Perelman School of MedicineUniversity of PennsylvaniaPhiladelphiaPennsylvaniaUSA From the Pharmacology Department (K.D., B.-S.D., S.Z., V.R.M.), Neurology Department (S.E.K.), and Pathology Department (D.B.C.), University of Pennsylvania, Philadelphia; Los Alamos National Laboratory, Los Alamos, NM (K.G.); Cardiovascular Research Center, Massachusetts General Hospital, Boston (D.A., P.L.H.); and Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (J.-C.M.). The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden;; Belozersky Institute of Physico-Chemical Biology and Faculty of Bioengineering and Bioinformatics, Lomonosov Moscow State University, Moscow, Russia; Department of Systems Pharmacology & Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA |
Incoming Links
Total number of triples: 64.